  
- 积分
- 97
- 威望
- 97
- 包包
- 3142
|
本帖最后由 bobo 于 2009-6-28 08:34 编辑 ! Y6 ~) A, {$ k" t# V- `/ ]
4 l% h" |1 }/ A3 U4 ]表观遗传学与干细胞——2009年亚洲生物高峰论坛录制(音频mp3)
- f& @3 g, `5 K" l; `4 G% _9 _$ n5 k5 @6 V- z
. H2 Q: o+ c4 J, ]" `3 V1 O; O |
! H6 o) l, y* Z9 y% ^# j6 V" d回复为ppt5 e" `4 M5 E3 M7 S1 Y+ X. B
摘要:; L+ _+ A) T/ Q, Y' J4 ]$ y# y" q
9 b' k' g+ _$ IHongkui Deng
/ v- A) t$ d k( H: d2 E
9 D- r. V; M0 c3 K' S, }0 \" ~2 zLaboratory of Stem Cell and Generative Biology, College of Life Sciences, Peking University, Beijing 100871, China.
9 J. g6 O$ R7 C/ C# N, U H; n+ {( J! F) A% [$ z: x& s, m
Human pluripotent stem cells represent a potentially unlimited source of functional pancreatic endocrine lineage cells. We established a new highly efficient approach to induce human embryonic stem (ES) cells and induced pluripotent stem (iPS) cells to differentiate into mature insulin-producing cells in a chemical-defined culture system. The differentiated cells obtained by this approach comprised nearly 25% insulin-positive cells as assayed by flow cytometry analysis, which released insulin/C-peptide in response to glucose stimuli in a manner comparable to that of adult human islets. Most of these insulin-producing cells co-expressed mature beta cell-specific markers such as NKX6-1 and PDX1, indicating a similar gene expression pattern to adult islet beta cells in vivo. This work provides a new model to study the mechanism of human pancreatic specialization and maturation in vitro, and enhances the possibility of utilizing patient-specific iPS cells for the treatment of diabetes
3 [9 Y, \. V9 I) z8 A' ^" @2 E0 K& X# _1 b7 y) b) f
回复为ppt$ m' `: v( A6 Y& K% c. @3 \1 ?. v
" B) f2 ^7 Y+ q, F c
6 O4 G/ |% x O( a' t4 w4 ^6 h* ?5 k( I2 E# ?1 f# ?7 A) i" L' h
1 j5 f, g! |1 q D+ R0 H! {# s) ? |
附件: 你需要登录才可以下载或查看附件。没有帐号?注册
|